4//SEC Filing
Evans Elizabeth E. 4
Accession 0001062993-22-009446
CIK 0001205922other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:33 PM ET
Size
12.6 KB
Accession
0001062993-22-009446
Insider Transaction Report
Form 4
VACCINEX, INC.VCNX
Evans Elizabeth E.
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-04-01+20,000→ 20,000 totalExercise: $1.29Exp: 2032-04-01→ Common Stock (20,000 underlying)
Holdings
- 9,600
Common Stock
- 9,610
Stock Option (Right to Buy)
Exercise: $7.10Exp: 2025-12-22→ Common Stock (9,610 underlying) - 8,605
Stock Option (Right to Buy)
Exercise: $7.10Exp: 2025-12-23→ Common Stock (8,605 underlying) - 12,400
Stock Option (Right to Buy)
Exercise: $3.90Exp: 2029-03-14→ Common Stock (12,400 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $3.82Exp: 2030-04-04→ Common Stock (10,000 underlying) - 8,000
Stock Option (Right to Buy)
Exercise: $2.93Exp: 2031-04-03→ Common Stock (8,000 underlying)
Footnotes (5)
- [F1]This option is fully exercisable as of the date of this report.
- [F2]This option has vested with respect to 9,300 shares and the remainder vests on March 15, 2023.
- [F3]This option has vested with respect to 5,000 shares and the remainder vests in two equal annual installments beginning on April 3, 2023.
- [F4]This option vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date.
- [F5]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date.
Issuer
VACCINEX, INC.
CIK 0001205922
Entity typeother
Related Parties
1- filerCIK 0001863447
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:33 PM ET
- Size
- 12.6 KB